Literature DB >> 33270889

MethHC 2.0: information repository of DNA methylation and gene expression in human cancer.

Hsi-Yuan Huang1,2, Jing Li1, Yun Tang1, Yi-Xian Huang1, Yi-Gang Chen1, Yue-Yang Xie1, Zhe-Yuan Zhou3, Xin-Yi Chen1, Si-Yuan Ding1, Meng-Fan Luo1, Chen-Nan Jin1, Le-Shan Zhao1, Jia-Tong Xu1, Ying Zhou1, Yang-Chi-Dung Lin1,2, Hsiao-Chin Hong1,2, Hua-Li Zuo1,2, Si-Yao Hu1,2, Pei-Yi Xu1, Xin Li1,2, Hsien-Da Huang1,2.   

Abstract

DNA methylation is an important epigenetic regulator in gene expression and has several roles in cancer and disease progression. MethHC version 2.0 (MethHC 2.0) is an integrated and web-based resource focusing on the aberrant methylomes of human diseases, specifically cancer. This paper presents an updated implementation of MethHC 2.0 by incorporating additional DNA methylomes and transcriptomes from several public repositories, including 33 human cancers, over 50 118 microarray and RNA sequencing data from TCGA and GEO, and accumulating up to 3586 manually curated data from >7000 collected published literature with experimental evidence. MethHC 2.0 has also been equipped with enhanced data annotation functionality and a user-friendly web interface for data presentation, search, and visualization. Provided features include clinical-pathological data, mutation and copy number variation, multiplicity of information (gene regions, enhancer regions, and CGI regions), and circulating tumor DNA methylation profiles, available for research such as biomarker panel design, cancer comparison, diagnosis, prognosis, therapy study and identifying potential epigenetic biomarkers. MethHC 2.0 is now available at http://awi.cuhk.edu.cn/∼MethHC.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2020        PMID: 33270889     DOI: 10.1093/nar/gkaa1104

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  9 in total

Review 1.  A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery.

Authors:  Gayathri Ashok; Sudha Ramaiah
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

2.  Integrating chromatin accessibility states in the design of targeted sequencing panels for liquid biopsy.

Authors:  Pegah Taklifi; Fahimeh Palizban; Mahya Mehrmohamadi
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

3.  Tumor Expression Quantitative Trait Methylation Screening Reveals Distinct CpG Panels for Deconvolving Cancer Immune Signatures.

Authors:  Xiaoqing Yu; Ling Cen; Y Ann Chen; Joseph Markowitz; Timothy I Shaw; Kenneth Y Tsai; Jose R Conejo-Garcia; Xuefeng Wang
Journal:  Cancer Res       Date:  2022-05-03       Impact factor: 13.312

4.  OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer.

Authors:  Gongyu Tang; Minsu Cho; Xiaowei Wang
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

5.  DiseaseMeth version 3.0: a major expansion and update of the human disease methylation database.

Authors:  Jie Xing; Ruiyang Zhai; Cong Wang; Honghao Liu; Jiaqi Zeng; Dianshuang Zhou; Mengyan Zhang; Liru Wang; Qiong Wu; Yue Gu; Yan Zhang
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

6.  EWAS Open Platform: integrated data, knowledge and toolkit for epigenome-wide association study.

Authors:  Zhuang Xiong; Fei Yang; Mengwei Li; Yingke Ma; Wei Zhao; Guoliang Wang; Zhaohua Li; Xinchang Zheng; Dong Zou; Wenting Zong; Hongen Kang; Yaokai Jia; Rujiao Li; Zhang Zhang; Yiming Bao
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

7.  ASMdb: a comprehensive database for allele-specific DNA methylation in diverse organisms.

Authors:  Qiangwei Zhou; Pengpeng Guan; Zhixian Zhu; Sheng Cheng; Cong Zhou; Huanhuan Wang; Qian Xu; Wing-Kin Sung; Guoliang Li
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

8.  CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.

Authors:  Kun He; Mengyi Xie; Jingdong Li; Yi He; Yaolin Yin
Journal:  Int J Gen Med       Date:  2022-09-25

9.  Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.

Authors:  Yuhua Chen; Jinjie Wang; Hao Zhou; Zhanghao Huang; Li Qian; Wei Shi
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.